Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Authors:
- 23 February 2024
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 26 (4) , 101052
Abstract
No abstract availableKeywords
Funding Information
- Children's Hospital of Philadelphia
This publication has 43 references indexed in Scilit:
- Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global PandemicJAMA Pediatrics, 2022
- Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinicsFertility and Sterility, 2020
- Comparing Within- and Between-Family Polygenic Score PredictionThe American Journal of Human Genetics, 2019
- Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platformEuropean Journal of Medical Genetics, 2019
- Who Should Regulate Preimplantation Genetic Diagnosis in the United States?AMA Journal of Ethics, 2018
- Forty years of IVFFertility and Sterility, 2018
- The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinionFertility and Sterility, 2018
- In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled studyFertility and Sterility, 2017
- Should preimplantation genetic screening (PGS) be implemented to routine IVF practice?Journal of Assisted Reproduction and Genetics, 2016
- The preimplantation genetic diagnosis of genetic diseasesJournal of Assisted Reproduction and Genetics, 1990